mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

Jacqueline K. Shaia; Priya Shukla; Lee Jampol; Rishi P. Singh

doi:10.1038/s41541-024-00983-0

mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

Jacqueline K. Shaia, Priya Shukla, Lee Jampol, Rishi P. Singh^*

^*Corresponding author for this work

Ophthalmology

Research output: Contribution to journal › Letter › peer-review

Abstract

Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.

Original language	English (US)
Article number	202
Journal	npj Vaccines
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41541-024-00983-0
State	Published - Dec 2024

ASJC Scopus subject areas

Immunology
Pharmacology
Infectious Diseases
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41541-024-00983-0

Cite this

@article{76bdc58c10c840cb8cc5fb59601bd36d,

title = "mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination",

abstract = "Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.",

author = "Shaia, {Jacqueline K.} and Priya Shukla and Lee Jampol and Singh, {Rishi P.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1038/s41541-024-00983-0",

language = "English (US)",

volume = "9",

journal = "npj Vaccines",

issn = "2059-0105",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

AU - Shaia, Jacqueline K.

AU - Shukla, Priya

AU - Jampol, Lee

AU - Singh, Rishi P.

N1 - Publisher Copyright: © The Author(s) 2024.

PY - 2024/12

Y1 - 2024/12

N2 - Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.

AB - Case reports have speculated if COVID-19 vaccinations may be associated with retinal vascular occlusions (RVO). Specifically, previous literature speculated an increased risk of RVOs days to weeks after vaccination. After reviewing two recent analyses, mRNA COVID-19 vaccinations do not appear to increase the risk of RVOs at 3 and 12 weeks post-vaccination. Although both studies had different designs, mRNA vaccines do not appear to influence the risk of RVO development.

UR - http://www.scopus.com/inward/record.url?scp=85208141931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85208141931&partnerID=8YFLogxK

U2 - 10.1038/s41541-024-00983-0

DO - 10.1038/s41541-024-00983-0

M3 - Letter

C2 - 39468063

AN - SCOPUS:85208141931

SN - 2059-0105

VL - 9

JO - npj Vaccines

JF - npj Vaccines

IS - 1

M1 - 202

ER -

mRNA COVID-19 vaccinations are not associated with RVO development 21 days and 12 weeks after vaccination

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this